The hemophagocytic lymphohistiocytosis treatment market is expanding, driven by new immunomodulatory treatments such as biologics and cell therapies, including CAR‑T and cytokine inhibitors tailored for this rare hyperinflammatory syndrome. https://www.datamintelligence.com/research-report/hemophagocytic-lymphohistiocytosis-treatment-market